Caring Brands, Inc. CABR
- Market cap
- —
- P/E
- 0.0×
Follow CABR
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | 0.71 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | — | 1.65 |
High Price
|
|||
| — | — | — | — | — | — | — | — | — | 3 |
Employees
|
|||
| — | — | — | — | — | — | — | — | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | — | 0 | 0 |
Revenue
|
|||
| — | — | — | — | — | — | — | — | (320.00%) | 54.76% |
Gross Margin
|
|||
| — | — | — | — | — | — | — | — | (2) | (6) |
EBT
|
|||
| — | — | — | — | — | — | — | — | (303,480.00%) | (149,480.95%) |
EBT Margin
|
|||
| — | — | — | — | — | — | — | — | (2) | (6) |
Net Income
|
|||
| — | — | — | — | — | — | — | — | 0 | 0 |
Depreciation
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | — | (0.12) | (0.46) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | — | (0.06) | (0.12) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | — | (0.06) | (0.12) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | — | 0.28 | 0.15 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | — | 13 | 14 |
Shares
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 2,777.62 |
PS Ratio
|
|||
| — | — | — | — | — | — | — | — | 4.29 | 5.58 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 2,270.35 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | — | (12.32) | (5.63) |
EV/FCF
|
|||
| — | — | — | — | — | — | — | — | (1) | (2) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | — | — | — | Capex | |||
| — | — | — | — | — | — | — | — | (1) | (2) |
FCF
|
|||
| — | — | — | — | — | — | — | — | 0 | 2 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | — | 0 |
Total Debt
|
|||
| — | — | — | — | — | — | — | — | 0 | (2) |
Net Debt
|
|||
| — | — | — | — | — | — | — | — | 4 | 2 |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | — | 0.00% | (202.38%) |
ROA
|
|||
| — | — | — | — | — | — | — | — | (29.62%) | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | — | 0.00% | (217.14%) |
ROE
|
|||
Caring Brands, Inc. (CABR) key facts
- Caring Brands, Inc. (CABR) is a Drug Manufacturers Specialty & Generic company in the Healthcare sector, listed on Nasdaq.
- Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024.
- Return on equity was −217.1% and debt-to-equity 0.00.
Caring Brands, Inc. (CABR) Latest News
2 Sep
Caring Brands Inc. (Nasdaq: CABR) completed the initial $4.6 million closing under its ongoing $9 million private placement. Private placement supplies $4.6 million in capital with moderate effects on operations.
6 Aug
Caring Brands, Inc. (CABR) provides an update on its intellectual property portfolio. Intellectual property updates can moderately strengthen asset protection and competitive positioning for Caring Brands, Inc. (CABR).
1 Jun
Caring Brands Inc. expanded its multi-territory licensing agreement with SanPellegrino Cosmetics Private Limited covering Photocil and Hair Enzyme Booster products. Expanded licensing agreement broadens product distribution and potential revenue streams for Caring Brands Inc.
3 Feb
Caring Brands, Inc. has secured two new U.S. patents that enhance its hair enzyme booster technology. These patents are expected to strengthen the company's product offerings and competitive position in the hair care market, potentially leading to increased consumer interest and sales. The acquisition of new patents is likely to significantly impact product innovation and market positioning.
5 Jan
Caring Brands, Inc. (CABR) has secured an exclusive global license to manufacture and market Emesyl, a product aimed at treating nausea and vomiting. This strategic move is expected to enhance CABR's product portfolio and market presence, potentially driving growth and expanding its reach in the healthcare sector. Acquiring an exclusive global license for a healthcare product is a significant strategic move that could enhance market positioning and financial performance.
14 Nov
Caring Brands, Inc. (CABR) has successfully completed a $4,000,000 uplisting to Nasdaq, enhancing its visibility and access to capital markets. This strategic move is expected to bolster the company's growth and investor interest. Uplisting to Nasdaq is a significant strategic move that can enhance market visibility and investor confidence.
13 Nov
Caring Brands, Inc. (CABR) experienced a notable decline in midday trading, contributing to its position among the top decliners in the market. The company's stock faced downward pressure, reflecting broader market trends and investor sentiment. Analysts are closely monitoring CABR's performance as it navigates these challenges, which could impact its future outlook. The decline in stock performance indicates a moderately noticeable influence on investor sentiment and market positioning.
12 Nov
Caring Brands, Inc. (CABR) has announced the pricing of its uplisting to Nasdaq, raising $4,000,000. This move is part of the company's strategy to enhance its visibility and access to capital markets, aiming to support future growth initiatives. Uplisting to Nasdaq is a significant strategic move that can enhance market visibility and investor sentiment.